| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 04/07/2010 | CN101199787B Medicament compound for treating skin disease |
| 04/07/2010 | CN101032607B Medicine for treating pointed condyloma |
| 04/07/2010 | CN101023945B Use of non-periphery substituted phthalocyaniu metal complex |
| 04/06/2010 | US7691973 GFRα3 polypeptides |
| 04/06/2010 | US7691967 Smart pro-drugs of serine protease inhibitors |
| 04/06/2010 | US7691903 Oxidation-sensitive hydrophilic active principle containing composition and use thereof |
| 04/06/2010 | US7691894 new crystals forms of Sodium trans-4-[1-[2,5-dichloro-4-[(1-methyl-1H-3-indolylcarbonyl)amino]phenylacetyl]-(4S)-methoxy(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylate pentahydrate; VLA-4 (very late antigen-4) inhibitor; therapeutic drug for disorders caused by cell adhesion; water soluble, stability |
| 04/06/2010 | US7691883 decreases expression of a Type I collage gene in a tissue to induce a reduction in accumulation of collagen and thereby improves tissue fibrosis |
| 04/06/2010 | US7691808 Use of Slurp-1 for treating diseases related to acetylcholine receptor dysfunction |
| 04/06/2010 | CA2475137C New heterocyclic oxime derivatives, their preparation process and the pharmaceutical compositions that contain them |
| 04/06/2010 | CA2455181C Benzimidazo[4,5-f]isoquinolinone derivatives |
| 04/06/2010 | CA2386017C Drug delivery of phase changing formulation |
| 04/06/2010 | CA2280873C The use of latency associated peptide in wound healing |
| 04/01/2010 | WO2010036947A2 Lipid based pharmaceutical preparations for oral and topical application; their compositions, methods, and uses thereof |
| 04/01/2010 | WO2010036111A1 Means and methods for counteracting, preventing and/or determining fibrosis or a risk of fibrosis |
| 04/01/2010 | WO2010035806A1 Solid pharmaceutical composition |
| 04/01/2010 | WO2010035769A1 Improved antibody molecule |
| 04/01/2010 | WO2010035745A1 Heterocyclic biaryl derivative, and pde inhibitor comprising same as active ingredient |
| 04/01/2010 | WO2010035675A1 Immunopotentiator or antiallergic agent |
| 04/01/2010 | WO2010035221A1 Pyrazolo pyridine derivatives as nadph oxidase inhibitors |
| 04/01/2010 | WO2010035220A1 Pyrazolo pyridine derivatives as nadph oxidase inhibitors |
| 04/01/2010 | WO2010035217A1 Pyrazolo pyridine derivatives as nadph oxidase inhibitors |
| 04/01/2010 | WO2010035013A1 Krill oil powder and krill oil tablets |
| 04/01/2010 | WO2010034917A2 Monoester of n-undecylenoyl phenylalanine and polyol, method for preparing same, and use of said esters as a skin lightening agent |
| 04/01/2010 | WO2010016965A9 Methods for treating injury associated with exposure to an alkylating species |
| 04/01/2010 | WO2010015965A3 Methods and compositions for treating neuronal damage and modulating transient receptor potential channels |
| 04/01/2010 | WO2010009369A3 Methods and materials for the treatment of acne |
| 04/01/2010 | WO2010006125A3 2-methylene-19,26-dinor-(20r,22e,25r)-vitamin d analogs |
| 04/01/2010 | WO2009154840A3 Compositions and methods using stem cells in cutaneous wound healing |
| 04/01/2010 | WO2009152374A3 Method for treating chronic wounds with an extracellular polymeric substance solvating system |
| 04/01/2010 | WO2009039743A8 Sirnas useful for inhibiting expression of tyrosinase gene, the compositions comprising the sirnas and their uses |
| 04/01/2010 | US20100081797 Manipulation of Cytokine Levels Using CD83 Gene Products |
| 04/01/2010 | US20100081721 Treatment of skin and mucosal superficial wounds using adrenergic receptor agonists |
| 04/01/2010 | US20100081689 Methods and Compositions for the Treatment of Iron Toxicity |
| 04/01/2010 | US20100081670 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases |
| 04/01/2010 | US20100081660 Novel Compounds Having Selective Inhibiting Effect at GSK3 |
| 04/01/2010 | US20100081645 Tricyclic heteroaryl compounds useful as inhibitors of janus kinase |
| 04/01/2010 | US20100081637 Eczema treatment with vitamin D and analogs thereof method, composition and cream |
| 04/01/2010 | US20100080856 Method and composition for postoperative wound healing |
| 04/01/2010 | US20100080854 Atopic dermatitis inducer |
| 04/01/2010 | US20100080853 Use of Spongilla Spicules as a Dermabrasion Device or Resurfacing Modality |
| 04/01/2010 | US20100080791 Composition and Method For Treating Tissue Defects |
| 04/01/2010 | US20100080787 Cosmetic or dermopharmaceutical composition comprising an enzyme which is insoluble in an aqueous medium as well as its uses |
| 04/01/2010 | US20100080782 Use of probiotic lactic acid bacteria for balancing the skin's immune system |
| 04/01/2010 | US20100080779 Methods related to wound healing |
| 04/01/2010 | US20100080762 Skin care composition |
| 04/01/2010 | DE102008042381A1 Emulgator-Systeme für kosmetische und pharmazeutische Öl-in-Wasser-Emulsionen Emulsifier systems for cosmetic and pharmaceutical oil-in-water emulsions |
| 04/01/2010 | CA2738147A1 Solid pharmaceutical composition |
| 03/31/2010 | EP2169059A1 Means and methods for counteracting, preventing and/or determining fibrosis or a risk of fibrosis |
| 03/31/2010 | EP2168984A1 Human antibodies that bind human IL-12 and methods for producing |
| 03/31/2010 | EP2168968A1 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors |
| 03/31/2010 | EP2168960A1 Pyrazolone derivative and pde inhibitor containing the same as active ingredient |
| 03/31/2010 | EP2168959A1 Pyridazinone derivative and pde inhibitor containing the same as active ingredient |
| 03/31/2010 | EP2168958A1 Isoindole-Imide Compounds, Compositions And Uses Thereof |
| 03/31/2010 | EP2168948A1 2-amino-nicotinamide derivatives and their use as vegf-receptor tyrosine kinase inhibitors |
| 03/31/2010 | EP2168579A1 Oral preparation comprising specific organic acid, and method for improvement in elution property and chemical stability of oral preparation |
| 03/31/2010 | EP2167474A1 Urocanic acid derivatives useful for the treatment of immune-related and inflammatory diseases |
| 03/31/2010 | EP2167108A1 Skin-derived precursor cells and uses thereof |
| 03/31/2010 | EP2167102A2 Use of hyaluronic acid for preparing compositions particularly for improving the function of skin, eye and mucous membrane protection |
| 03/31/2010 | EP2167078A2 Use of pactimibe for the preparation of a drug intended to prevent or treat a disease caused by a sebaceous gland dysfunction in humans or animals |
| 03/31/2010 | EP2167073A1 Terpenes with antifungal activity against malassezia yeasts |
| 03/31/2010 | EP2167072A1 Use of oleocanthal for treatment of cutaneous inflammation |
| 03/31/2010 | EP2167067A1 Use of eflucimibe for the production of a medicament for the prevention or treatment of a disease caused by sebaceous gland dysfunction in humans or animals |
| 03/31/2010 | EP2167062A1 Compositions and uses comprising a retinoid compound, an anti-irritant compound and benzoyl peroxide in acne |
| 03/31/2010 | EP1630165B1 [1,2,4]TRIAZOLO[1,5-a]PYRIMIDIN-2-YLUREA DERIVATIVE AND USE THEREOF |
| 03/31/2010 | EP1194168B1 Methods and products for manipulating uncoupling protein expression |
| 03/31/2010 | CN101687819A Novel preparation for external use |
| 03/31/2010 | CN101687786A Hydroxylamine compounds and methods of their use |
| 03/31/2010 | CN101686957A Combination comprising pyrrolidone-5-carboxylic acid and at least one compound from citrulline, arginine and asparagine, and use thereof in the treatment of atopic dermatitis |
| 03/31/2010 | CN101686954A Inhibition of AGE formation |
| 03/31/2010 | CN101686919A Use of citrulline for the treatment of conditions linked to an increase in protein carbonylation |
| 03/31/2010 | CN101686918A Slimming composition |
| 03/31/2010 | CN101684106A Thiazole onium salt compound and application for treating diseases relative to protein aging thereof |
| 03/31/2010 | CN101684091A cannabinoid receptor ligands |
| 03/31/2010 | CN101683520A Methods for treating tweak-related conditions |
| 03/31/2010 | CN101683500A Chinese herbal medicament ointment for external use for treating folliculitis and preparation method thereof |
| 03/31/2010 | CN101683468A Medicament for treating burns and scalds and preparation method thereof |
| 03/31/2010 | CN101683440A Pharmaceutical composition for promoting hair growth |
| 03/31/2010 | CN101683435A Preparation method of pill containing black beans for blackening hair |
| 03/31/2010 | CN101683427A Traditional Chinese medicine composition and preparation method thereof |
| 03/31/2010 | CN101683369A Medicament for treating skin tinea disease |
| 03/31/2010 | CN101683364A Skin ointment |
| 03/31/2010 | CN101683344A Nutritious mixture of amino acid and vitamin for preventing hair losing and improving hair growing |
| 03/31/2010 | CN101683334A (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof |
| 03/31/2010 | CN101683311A Uses of dithiolane compounds for the photoprotection of the skin, dithiolane compounds and compositions containing same |
| 03/31/2010 | CN101683310A Anthranilic acid amides and the derivatives thereof as cosmetic and pharmaceutical agents |
| 03/31/2010 | CN101683308A Emulsifier systems for cosmetic and pharmaceutical oil-in-water emulsions |
| 03/31/2010 | CN101683108A Ginger and honeysuckle composite flavor soft ice cream size and preparation method thereof |
| 03/30/2010 | US7687643 For angiogenesis mediated diseases; cancer; acylation, cyclization and Heck-type reduction |
| 03/30/2010 | US7687637 5-phenylthiazole derivatives and use as Pi3 kinase inhibitors |
| 03/30/2010 | US7687606 Fully human monoclonal antibodies that inhibit neovascularization of solid tumors; assaying for MCP-1; cancer diagnosis; may be conjugated to a chemotherapeutic agent such as taxol, doxorubicin, cis-platinum, and 5-fluorouracil. |
| 03/30/2010 | US7687543 Use of polyunsaturated ketones for the treatment of psoriasis |
| 03/30/2010 | US7687507 Protein tyrosine kinase, such as Janus Kinase 3, inhibitors, immunosuppressants; organ transplants, lupus, multiple sclerosis, psoriasis; antidiabetic agents, antiarthritic agents, anticarcinogenic agents, Alzheimer's Disease, Crohn's Disease, Inflammatory Bowel Disease, autoimmune thyroid disorders |
| 03/30/2010 | US7687505 Use of modified pyrimidine compounds to promote stem cell migration and proliferation |
| 03/30/2010 | US7687457 Cyclic molecular framework and derivatives thereof |
| 03/30/2010 | US7687083 Pharmaceutical compositions comprising old man's beard (Usnea barbata) and St. John's wort (Hypericum perforatum) and their use |
| 03/30/2010 | US7687074 Prevent adhesion of pathogens; mixture containing fatty acid, or glycerides thereof |
| 03/30/2010 | US7687059 Systems and methods for treating patients with processed lipoaspirate cells |
| 03/30/2010 | US7687055 The invention relates to the use of creatine, creatinine and/or derivatives thereof and/or their salts in an agent for hardening, strengthening, restructuring or increasing the shine, volume or combability of keratin fibers, particularly |
| 03/30/2010 | CA2380451C Primary composition containing a lipophilic bioactive compound |